👀 Ones to watch: The MOST undervalued stocks to buy right nowSee Undervalued Stocks

U.S. stocks are climbing ahead of busy earnings week

Published 2023-07-17, 10:12 a/m
© Reuters.
XAU/USD
-
US500
-
DJI
-
MSFT
-
GS
-
JPM
-
ATVI
-
GC
-
LCO
-
CL
-
NFLX
-
TSLA
-
IXIC
-
BBIO
-

Investing.com -- U.S. stocks are muted ahead of a heavy week of earnings reports.

At 9:53 ET (13:53 GMT), the Dow Jones Industrial Average was up 18 points or less than 0.1%, while the S&P 500 was up 0.1% and the NASDAQ Composite was up 0.3%.

This week features a number of earnings reports from large companies, including Goldman Sachs (NYSE:GS), Tesla, Inc. (NASDAQ:TSLA), and Netflix (NASDAQ:NFLX). They follow reports last week from big banks, including JPMorgan Chase (NYSE:JPM).

Stocks rose last week on positive inflation news

Of the 30 S&P 500 companies to report so far, about 80% have beaten expectations, according to Refinitiv.

Stocks rose last week after consumer price index and producer price reports for June that had prices cooling faster than expected, stoking hopes that the Federal Reserve could get to the end of its interest rate increases sooner rather than later.

Other data expected this week include retail sales and a slew of housing market data, including existing home sales.

Microsoft court decision could lead to more M&A

The big banks to report so far saw a revenue boost from higher interest rates and said the economy remains resilient. A judge’s decision last week to clear Microsoft (NASDAQ:MSFT) to complete its deal to buy Activision Blizzard (NASDAQ:ATVI) is fueling hopes that more deals could be coming. That could be good news for banks like Goldman that depend on revenue from merger advisory and capital markets activity.

Activision Blizzard shares rose 2.9% after Microsoft agreed to keep the game Call of Duty on Sony PlayStation once their transaction is complete.

Tesla rolls out Cybertruck

Tesla shares were rising 2.7% after the electric vehicle maker rolled out its Cybertruck, four years after first unveiling the prototype.

BridgeBio Pharma, Inc. (NASDAQ:BBIO) shares soared 61% after it said an experimental heart disease drug significantly improved reducing hospitalizations.

Oil was falling. Crude Oil WTI Futures was down 0.8% to $74.66 a barrel, while Brent Oil Futures crude was down 0.9% to $79.12 a barrel. Gold Futures fell 0.6% to $1,952.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.